# Roche Diagnostics GmbH - Inspection Records

Source: https://www.keypedia.com/companies/roche-diagnostics-gmbh/a09aff2c-624a-48aa-b33e-fae16aa146f8

> Inspection records and compliance data for Roche Diagnostics GmbH in Penzberg, None. Access full analysis and detailed observations.

---

## Details

- Name: Roche Diagnostics GmbH
- FEI Number: 3002806560
- City: Penzberg
- State: None
- Country Name: Germany
- Address Line 1: Nonnenwald 2
- Zip Code: None

## Related Documents

- [483 - Roche Diagnostics GmbH - Unknown Date](https://www.keypedia.com/records/483/roche-diagnostics-gmbh/06ecc49c-2224-462e-b964-933d319f0b17) — source: FDA, date: Invalid Date
- [483 - Roche Diagnostics GmbH - 2025-08-01](https://www.keypedia.com/records/483/roche-diagnostics-gmbh/bebca28c-5fa2-42b5-a72f-fb536d469d06) — source: FDA, date: August 1, 2025
- [FDA Inspection 1277484 - Roche Diagnostics GmbH - 2025-08-01](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/b6047294-4f5d-4c5d-9fe7-d1733ea1967d) — source: FDA, date: August 1, 2025
- [FDA Inspection 1290452 - Roche Diagnostics GmbH - 2025-05-22](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/0325252f-5b8f-400b-b4b4-f039baa430ab) — source: FDA, date: May 22, 2025
- [FDA Inspection 1290452 - Roche Diagnostics GmbH - 2025-05-22](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/e66527d4-c20a-4b20-97f4-7407e4eb429a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2025
- [483 - Roche Diagnostics GmbH - 2023-03-10](https://www.keypedia.com/records/483/roche-diagnostics-gmbh/a55e0790-80d7-4185-972d-db8f3900367c) — source: FDA, date: March 10, 2023
- [FDA Inspection 1199547 - Roche Diagnostics GmbH - 2023-03-10](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/6382bdc3-9037-4345-b2f8-2d537fabb357) — source: FDA, date: March 10, 2023
- [FDA Inspection 1137525 - Roche Diagnostics GmbH - 2020-09-16](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/c60109aa-2f32-4241-af2d-7b8bcd7e7d8d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2020
- [FDA Inspection 1054436 - Roche Diagnostics GmbH - 2018-04-12](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/91dc71a0-abd9-449f-ad78-8f682ea10db5) — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2018
- [FDA Inspection 1054436 - Roche Diagnostics GmbH - 2018-04-12](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/fdc66548-8f43-4aba-bf4d-c5929dac3064) — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2018
- [FDA Inspection 975397 - Roche Diagnostics GmbH - 2016-04-29](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/d75bb678-727d-43df-afd8-c9393d2753a9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2016
- [FDA Inspection 928456 - Roche Diagnostics GmbH - 2015-05-20](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/846ac9c8-a73d-417e-8ca4-f61a34a32200) — classification: No Action Indicated (NAI), source: FDA, date: May 20, 2015
- [FDA Inspection 881599 - Roche Diagnostics GmbH - 2014-05-16](https://www.keypedia.com/records/fda_inspections/roche-diagnostics-gmbh/02ad8315-d9f9-48e4-815a-a619f3ff4b16) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2014

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/d87c0898-93b6-4200-b7b3-805ee819abb4)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Shandong Xinhua Pharmaceutical Company Limited](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e)
- [Neuland Laboratories Limited (Unit I)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5)
- [Medichem, S.A.](https://www.keypedia.com/companies/medichem-sa/a0e6f1b5-f2ab-4695-a0e9-007630ef1270)

## Related Officers

- [Michael R. Shanks, Senior Biologist](https://www.keypedia.com/people/michael-r-shanks-senior-biologist/619295e6-cb39-4125-9a56-171774ce2cd5)
- [Drug Discovery and Biotech Executive](https://www.keypedia.com/people/lloyd-d-payne/8b98c38a-4fbe-465d-bb0a-689bcc6db702)
- [Shadia Zaman](https://www.keypedia.com/people/shadia-zaman/c534a993-7a9b-401e-bfe7-b209a916cf6e)
- [Kyunghun Park](https://www.keypedia.com/people/kyunghun-park/c1aac046-d200-42bf-b91d-0a89edc7e375)
- [Cody D. Rickman](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)
- [investigator](https://www.keypedia.com/people/mizanne-e-lewis/c79964ac-5163-44a2-89e9-8cc8775de9b4)